As of Nov 27
| +0.53 / +0.77%|
The 5 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 83.00, with a high estimate of 105.00 and a low estimate of 70.00. The median estimate represents a +20.20% increase from the last price of 69.05.
The current consensus among 5 polled investment analysts is to Hold stock in Agios Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.